Cost-effectiveness of using HAART in prevention of mother-to-child transmission in the DREAM-Project Malawi.

MLA

Orlando, Stefano, et al. “Cost-Effectiveness of Using HAART in Prevention of Mother-to-Child Transmission in the DREAM-Project Malawi.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 55, no. 5, Dec. 2010, pp. 631–34. EBSCOhost, https://doi.org/10.1097/QAI.0b013e3181f9f9f5.

APA

Orlando, S., Marazzi, M. C., Mancinelli, S., Liotta, G., Ceffa, S., Giglio, P., Alumando, E., Ziegler, I., Shawa, M., & Palombi, L. (2010). Cost-effectiveness of using HAART in prevention of mother-to-child transmission in the DREAM-Project Malawi. Journal of Acquired Immune Deficiency Syndromes (1999), 55(5), 631–634. https://doi.org/10.1097/QAI.0b013e3181f9f9f5

Chicago

Orlando, Stefano, Maria Cristina Marazzi, Sandro Mancinelli, Giuseppe Liotta, Susanna Ceffa, Pietro Giglio, Ellard Alumando, Isabelle Ziegler, Mary Shawa, and Leonardo Palombi. 2010. “Cost-Effectiveness of Using HAART in Prevention of Mother-to-Child Transmission in the DREAM-Project Malawi.” Journal of Acquired Immune Deficiency Syndromes (1999) 55 (5): 631–34. doi:10.1097/QAI.0b013e3181f9f9f5.